International Union of Basic and Clinical Pharmacology

Last updated
International Union of Basic and Clinical Pharmacology
AbbreviationIUPHAR
Formation1959;64 years ago (1959)
Type INGO
Region served
Worldwide
Official language
English
Parent organization
 International Council for Science
Website IUPHAR Official website

The International Union of Basic and Clinical Pharmacology (IUPHAR) is a voluntary, non-profit association representing the interests of scientists in pharmacology-related fields to facilitate Better Medicines through Global Education and Research around the world.

Contents

History

Established in 1959 as a section of the International Union of Physiological Sciences, IUPHAR became an independent organization in 1966 [1] and is a member of the International Council for Science (ICSU). [2] The first World Congress of Pharmacology was held in Stockholm, Sweden in 1961 and subsequently held every three years. After 1990 the World Congresses were moved to a four-year interval. [3] These meetings present the latest pharmacological research, technology, and methodology, and provide a forum for international collaboration and exchange of ideas. A General Assembly, consisting of delegates from all the member societies, is convened during the congresses so member societies have an opportunity to elect the Executive Committee and vote on matters concerning the governance and activities of the union.

Members

IUPHAR members are regional, national and special-interest societies around the world. [4] The various sections and committees are composed of individuals from academia, pharmaceutical companies, and government organizations. IUPHAR resources are available to all members of the pharmacology-related societies that adhere to IUPHAR.

Composition

IUPHAR is divided in sectional topics. The Division of Clinical Pharmacology, including 3 subcommittees of Developing Countries, [5] Geriatrics, [6] and Pharmacoepidemiology and Pharmacovigilance, focuses on the needs and research tools for clinicians. The Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) provides a uniform guideline for naming and classifying results from the Human Genome Project, naming proteins derived from new sequences as functional receptors and ion channels. Sections specializing in various areas of pharmacology have been established, including Drug Metabolism and Drug Transport, [7] Education, [8] Gastrointestinal Pharmacology, [9] Immunopharmacology, [10] Pharmacology of Natural products, [11] Neuropsychopharmacology, [12] Pediatrics Clinical Pharmacology [13] and Pharmacogenetics and Pharmacogenomics. [14] Volunteers participate in the various sections and division according to their interests and training.

Activities

A primary purpose of IUPHAR is providing global free access to a major, on-line repository of characterization data for receptors, ion channels, enzyme target classes and drugs through the Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR), established in 1987. The Guide to Pharmacology established in 2012 superseded the earlier IUPHAR-DB. This is a joint endeavor with the British Pharmacological Society, and has been supported by the Wellcome Trust. It includes all the G protein-coupled receptors, voltage-gated ion channels, 7TM receptors, nuclear receptors, ligand-gated ion channels and Kinases which are known to be in the human genome. Where relevant, data on the rat and mouse homologues are presented to assist researchers and clinicians in developing and/or enhancing therapeutics for eventual medication in humans.

NC-IUPHAR also promulgates standards of name nomenclature for research in pharmacology and the related disciplines.

In general, IUPHAR offers individual pharmacologists free curriculum expertise, career development and job listings (the non-profit PharmacoCareers.org [15] ), research resources, and collaboration opportunities. IUPHAR offers its member societies venues for participating in worldwide initiatives, publicizing member meetings and activities, nominating individuals for Young Investigator awards, and naming delegates to the quadrennial General Assemblies. A biannual newsletter entitled Pharmacology International is published. [16]

As a non-government organization in official relations with the World Health Organization (WHO), IUPHAR representatives help shape international policy on essential medicines, appropriate dose therapeutics for children, and clinical pharmacology core competencies among its many WHO-related activities.

The Division of Clinical Pharmacology compiled and released the Research in Humans Compendium, [17] a free resource to provide the scientific community interested in human research with information on the design of research protocols to assess the effectiveness of a drug in a series of pathological conditions.

IUPHAR is involved in the development of pharmacology in developing countries. In conjunction with ICSU the Pharmacology for Africa (PharfA) initiative was undertaken in 2006 to promote and organize pharmacology on the African continent. The South African Society of Basic and Clinical Pharmacology is building a database and network of institutions and pharmacologists to create an infrastructure for training and funding pharmacologists. The long-term goal is for the African continent to attain the necessary pharmacological knowledge and resources to address disease-related issues affecting the population. As part of this mission, with the support of ICSU and the American Society for Pharmacology and Experimental Therapeutics, the IUPHAR Education Section organized a series of workshops, mostly in Africa, to train young investigators on ethical laboratory practices, including the three Rs of ethical use of animals.

IUPHAR Pharmacology Education Project [18] is a website developed by IUPHAR, with support from the American Society for Pharmacology and Experimental Therapeutics (ASPET), as a learning resource to support education and training in the pharmacological sciences. The materials are intended for use by students of pharmacology, clinical pharmacologists, and others interested in the pharmacological sciences. The stated aim is to produce a simple, attractive, easily searchable resource that will support students and teachers of the biomedical sciences, medicine, nursing and pharmacy. It is also intended as an introduction to some of the new data in the IUPHAR/BPS Guide to PHARMACOLOGY, particularly for those less familiar with such material.

Future directions

The early years of the 21st century will be focused on integrating basic and clinical research to implement translational medicine techniques more quickly. The 9th World Conference on Clinical Pharmacology and Therapeutics in Québec City, Canada was the last IUPHAR meeting to present clinical pharmacology separately. The World Congress of Basic and Clinical Pharmacology in Copenhagen, Denmark on July 17–23, 2010 [19] was the first integrated meeting. The merging of these different approaches to the same discipline is to accelerate the introduction of improved therapeutics for humans.

Educational components will be emphasized for both existing pharmacology programs as well as increasing and enhancing pharmacology training in developing countries. This topic was a central theme of the 17th World Congress of Basic and Clinical Pharmacology (WCP2014) held July 13–18, 2014 in Cape Town, South Africa. [20] The 18th World Congress of Basic and Clinical Pharmacology (WCP2018) being held in Kyoto, Japan on July 1–6, 2018 will focus on drug development and therapeutics using new methodologies such as genome sequencing, stem cell biology, nanotechnology and systems biology. [21]

See also

Related Research Articles

<span class="mw-page-title-main">Pharmacology</span> Branch of biology concerning drugs

Pharmacology is a branch of medicine, biology, and pharmaceutical sciences concerned with drug or medication action, where a drug may be defined as any artificial, natural, or endogenous molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism. It is the science of drugs including their origin, composition, pharmacokinetics, therapeutic use, and toxicology. More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.

<span class="mw-page-title-main">Pharmacogenomics</span> Study of the role of the genome in drug response

Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of a patient affects their response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response, by correlating DNA mutations with pharmacokinetic, pharmacodynamic, and/or immunogenic endpoints.

Clinical pharmacology is "that discipline that teaches, does research, frames policy, gives information and advice about the actions and proper uses of medicines in humans and implements that knowledge in clinical practice". Clinical pharmacology is inherently a translational discipline underpinned by the basic science of pharmacology, engaged in the experimental and observational study of the disposition and effects of drugs in humans, and committed to the translation of science into evidence-based therapeutics. It has a broad scope, from the discovery of new target molecules to the effects of drug usage in whole populations. The main aim of clinical pharmacology is to generate data for optimum use of drugs and the practice of 'evidence based medicine'.

<span class="mw-page-title-main">Opioid peptide</span> Class of peptides that bind to opioid receptors

Opioid peptides or opiate peptides are peptides that bind to opioid receptors in the brain; opiates and opioids mimic the effect of these peptides. Such peptides may be produced by the body itself, for example endorphins. The effects of these peptides vary, but they all resemble those of opiates. Brain opioid peptide systems are known to play an important role in motivation, emotion, attachment behaviour, the response to stress and pain, control of food intake, and the rewarding effects of alcohol and nicotine.

Big dynorphin is an endogenous opioid peptide of the dynorphin family that is composed of both dynorphin A and dynorphin B. Big dynorphin has the amino acid sequence: Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr. It has nociceptive and anxiolytic-like properties, as well as effects on memory in mice.

Dopamine receptor D<sub>1</sub> Protein-coding gene in the species Homo sapiens

Dopamine receptor D1, also known as DRD1. It is one of the two types of D1-like receptor family - receptors D1 and D5. It is a protein that in humans is encoded by the DRD1 gene.

The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a scientific society founded in late 1908 by John Jacob Abel of Johns Hopkins University, with the aim of promoting the growth of pharmacological research. Many society members are researchers in basic and clinical pharmacology who help develop disease-fighting medications and therapeutics. ASPET is one of the constituent societies of the Federation of American Societies for Experimental Biology (FASEB). The society's headquarters are in Rockville, MD. The current president is Michael F. Jarvis.

Donald Robert James Singer was a British clinical pharmacologist who was the president of the Fellowship of Postgraduate Medicine.

<span class="mw-page-title-main">European Association for Clinical Pharmacology and Therapeutics</span>

The European Association for Clinical Pharmacology and Therapeutics (EACPT) is a learned society in the field of clinical pharmacology. It is the leading society in Europe serving the European and global Clinical Pharmacology and Therapeutics community. It has its origins in a working party in the early 1980s under the auspices of the World Health Organization (WHO-Europe). Subsequently, a committee was created in 1993 chaired by Folke Sjöqvist with the remit to prepare the first congress of EACPT, held in Paris in 1995. At that congress the founding EACPT Council elected an Executive Committee with Sjöqvist as chairman, Michael Orme as Honorary Secretary, Jochen Kuhlmann (Germany) as Treasurer, and Giampaolo Velo (Italy) as Vice-Chairman, with 26 European countries as members through their home country clinical pharmacology society or section. The EACPT now includes all national organisations for clinical pharmacology in Europe and provides educational and scientific support for the more than 4000 individual professionals interested in Clinical Pharmacology and Therapeutics throughout the European region, with its congresses attended by a global audience.

<span class="mw-page-title-main">Raymond P. Ahlquist</span> American pharmacist and pharmacologist (1914–1983)

Raymond Perry Ahlquist was an American pharmacist and pharmacologist. He published seminal work in 1948 that divided adrenoceptors into α- and β-adrenoceptor subtypes. This discovery explained the activity of several existing drugs and also laid the ground work for new drugs including the widely prescribed beta blockers.

The IUPHAR/BPS Guide to PHARMACOLOGY is an open-access website, acting as a portal to information on the biological targets of licensed drugs and other small molecules. The Guide to PHARMACOLOGY is developed as a joint venture between the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS). This replaces and expands upon the original 2009 IUPHAR Database. The Guide to PHARMACOLOGY aims to provide a concise overview of all pharmacological targets, accessible to all members of the scientific and clinical communities and the interested public, with links to details on a selected set of targets. The information featured includes pharmacological data, target, and gene nomenclature, as well as curated chemical information for ligands. Overviews and commentaries on each target family are included, with links to key references.

The Federation of European Pharmacological Societies (EPHAR) is a non-profit voluntary association established to advance research and education in the science of pharmacology and to promote co-operation between national/regional pharmacological societies in Europe and surrounding countries. It is an umbrella organization of currently 29 national societies for pharmacology and represents over 12,000 individual pharmacologists in Europe. Moreover it seeks to co-operate with other international organizations, especially the International Union of Basic and Clinical Pharmacology (IUPHAR) of which EPHAR is an associate member.

<span class="mw-page-title-main">Urs A. Meyer</span>

Urs Albert Meyer is a Swiss physician-scientist and clinical pharmacologist.

<span class="mw-page-title-main">Aticaprant</span> Chemical compound

Aticaprant, also known by its developmental codes JNJ-67953964, CERC-501, and LY-2456302, is a κ-opioid receptor (KOR) antagonist which is under development for the treatment of major depressive disorder. A regulatory application for approval of the medication is expected to be submitted by 2025. Aticaprant is taken by mouth.

Arthur Christopoulos is an Australian Professor of Analytical Pharmacology at Monash University. He is the recipient of numerous national and international awards, including the 2013 John J. Abel Award from the American Society for Pharmacology and Experimental Therapeutics and the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, the 2014 IUPHAR Analytical Pharmacology Lecturer, a 2015 Doctor of Laws from the National and Kapodistrian University of Athens, Greece, the 2016 recipient of the Gaddum Memorial Award from the British Pharmacological Society and the 2016 GSK Award for Research Excellence. Since 2014, Clarivate Analytics has regularly named him a Highly Cited Researcher in Pharmacology and Toxicology. In 2021, Arthur was named a Highly Cited Researcher in both Pharmacology and Toxicology and Biology and Biochemistry categories. In 2017 he was elected a Fellow of the Australian Academy of Health and Medical Sciences and in 2018 he was elected as a Fellow of the British Pharmacological Society. He was a Councillor of the International Union of Basic and Clinical Pharmacology from 2018 to 2022. In 2019 he was appointed Dean of Monash University's Faculty of Pharmacy and Pharmaceutical Sciences and from 2021 to 2023 he served as the inaugural Director of Monash University's Neuromedicines Discovery Centre. He was elected a Fellow of the Australian Academy of Science in 2021.

Professor Sir Munir Pirmohamed is a British clinical pharmacologist and geneticist. Since 2007 he has been the NHS Chair of Pharmacogenetics at the University of Liverpool.

<span class="mw-page-title-main">Salomon Z. Langer</span>

Salomon Zender Langer is an Argentinian pharmacologist whose family had fled from Poland to Argentina in the early 1930s and were thus saved from the Holocaust during the Second World War.

Sir Colin Terence Dollery was a clinical pharmacologist who spent much of his life working for SmithKline Beecham and its successor, Glaxo Smith Kline. He was knighted in the Queen's 1987 birthday honours. He was an honorary fellow of the British Pharmacological Society and a fellow of the Academy of Medical Sciences.

Eva King Killam was a research pharmacologist who studied the activity of drugs on the brain and behavior, developing animal models for epilepsy and opiate dependence.

<span class="mw-page-title-main">Matthias Schwab (pharmacologist)</span> German pharmacologist

Matthias Schwab is a German doctor and university lecturer. He is director of the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology located on the campus of the Robert-Bosch-Hospital in Stuttgart, an institution of the Robert Bosch Stiftung, and holder of the Chair of Clinical Pharmacology at the University of Tübingen as well as Medical Director of the Department of Clinical Pharmacology at the University Hospital Tübingen.

References

  1. ↑ Uvnäs, Börne (1984). "From Physiologist to Pharmacologist - Promotion or Degradation". Annu. Rev. Pharmacol. Toxicol. 24: 1–19. doi: 10.1146/annurev.pa.24.040184.000245 . PMID   6375544.
  2. ↑ "ICSU Scientific Unions". Archived from the original on 19 December 2015. Retrieved 16 September 2015.
  3. ↑ "IUPHAR Congresses". Archived from the original on 9 October 2015. Retrieved 16 September 2015.
  4. ↑ "IUPHAR Member Societies". Archived from the original on 25 December 2015. Retrieved 16 September 2015.
  5. ↑ "Developing Countries". IUPHAR Subcommittee for Clinical Pharmacology in Developing Countries. Retrieved 20 May 2016.
  6. ↑ "Geriatrics". IUPHAR Geriatric Pharmacology Subcommittee. Retrieved 20 May 2016.
  7. ↑ "Drug Metabolism and Drug Transport". IUPHAR Drug Metabolism & Drug Transport Section. Archived from the original on 9 October 2015. Retrieved 16 September 2015.
  8. ↑ "Education". IUPHAR Education Section. Retrieved 16 September 2015.
  9. ↑ "Gastrointestinal Pharmacology". IUPHAR Gastrointestinal Pharmacology Section. Retrieved 16 September 2015.
  10. ↑ "Immunopharmacology". IUPHAR Immunopharmacology Section. Retrieved 16 September 2015.
  11. ↑ "Pharmacology of Natural Products". IUPHAR Pharmacology of Natural Products Section. Retrieved 16 September 2015.
  12. ↑ "Neuropsychopharmacology". IUPHAR Neuropsychopharmacology Section. Retrieved 19 May 2016.
  13. ↑ "Pediatric Clinical Pharmacology". IUPHAR Pediatric Clinical Pharmacology Section. Retrieved 16 September 2015.
  14. ↑ "Pharmacogenetics and Pharmacogenomics". IUPHAR Pharmacogenetics-genomics Section. Archived from the original on 9 October 2015. Retrieved 16 September 2015.
  15. ↑ "IUPHAR Career Center". PharmacoCareers. Retrieved 16 September 2015.
  16. ↑ "Pharmacology International Newsletters". Iuphar.org. 9 December 2015. Archived from the original on 27 November 2015. Retrieved 1 June 2016.
  17. ↑ "Research in Humans Compendium". IUPHAR Clinical Pharmacology Division Publications. Retrieved 16 September 2015.
  18. ↑ "IUPHAR Pharmacology Education Project". IUPHAR Pharmacology Education Project. Retrieved 20 May 2016.
  19. ↑ "WorldPharma 2010". worldpharma1010.org. 2010. Archived from the original on 28 September 2015. Retrieved 1 June 2016.
  20. ↑ "17th World Congress of Basic and Clinical Pharmacology (WCP2014)". Wcp2014.org. Retrieved 1 June 2016.
  21. ↑ "18th World Congress of Basic and Clinical Pharmacology (WCP2018)". Wcp2018.org. Retrieved 1 June 2016.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.